When top-level enterprise executives think of cybersecurity threats, they tend to picture things like malware, ransomware, ...

The FDA’s Marty Makary and Vinay Prasad have laid out a path for CRISPR treatments on demand. An expert weighs in on what it ...

The telecom cloud market, valued at USD 30.23 billion in 2025E, is projected to witness substantial growth through 2033, driven by rapid advancements in network virtualization, scalability, and ...

Meta wants creators using Instagram's new app Edits. We spoke with a Meta exec about the app's growth.

CRISPR-based technology is advancing rapidly, driving international competition. Its promise to transform medicine is colliding with political and social realities, even as applications expand.

H. Lundbeck A/S (Lundbeck) today announced the acceptance of its new drug application (NDA) for Vyepti® (eptinezumab) by the Ministry of Health, Labor and Welfare (MHLW) in Japan.

Understanding, organizing, and validating data directly affects the accuracy of stories. New tools make cleaning accessible ...

Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common ...